It seems that NCAPH2 methylation is a useful peripheral biomarker to be used in combination with the analysis of genetic risk alleles to identify the disease pathogenesis, especially in the SCD APOE ε4-non-carriers risk population (Di Francesco et al., 2015). Here, APOE is linked to Schnyder corneal dystrophy.